Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjuan Sheng

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Physics in Medicine and Biology|May 29, 2020
A sequential regularization based image reconstruction method for limited-angle spectral CTWenjuan Sheng, Xing Zhao, Mengfei Li
Optics Express|November 23, 2021
Hysteresis and temperature drift compensation for FBG demodulation by utilizing adaptive weight least square support vector regressionWenjuan Sheng, Haiqi Dang, G D Peng
Optics Express|May 9, 2023
Drift calibration method of Fabry-Perot filters using two-stage decomposition and hybrid modelingWenjuan Sheng, Jun Zhan, Jianxiang Wen, et al.
Journal of Ethnopharmacology|September 30, 2023
Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathwayChijun Hou, Xinyue Jiang, Wenjuan Sheng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Physics in Medicine and Biology|May 29, 2020
A sequential regularization based image reconstruction method for limited-angle spectral CTWenjuan Sheng, Xing Zhao, Mengfei Li
Optics Express|November 23, 2021
Hysteresis and temperature drift compensation for FBG demodulation by utilizing adaptive weight least square support vector regressionWenjuan Sheng, Haiqi Dang, G D Peng
Optics Express|May 9, 2023
Drift calibration method of Fabry-Perot filters using two-stage decomposition and hybrid modelingWenjuan Sheng, Jun Zhan, Jianxiang Wen, et al.
Journal of Ethnopharmacology|September 30, 2023
Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathwayChijun Hou, Xinyue Jiang, Wenjuan Sheng, et al.
Pageof 1